Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension
Clinical trial NCT04951284 · TERMINATED
Trial details
- NCT number
- NCT04951284
- Sponsor
- Novoic Limited
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-21
- Primary completion
- 2022-11-21
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.